Rodman & Renshaw Initiates Coverage On Mira Pharmaceuticals With Buy Rating, Announces Price Target of $17
Rodman & Renshaw Initiates Coverage On Mira Pharmaceuticals With Buy Rating, Announces Price Target of $17
羅德曼與倫肖啓動對米拉制藥的覆蓋，給予買入評級，並宣佈目標股價爲17美元
Rodman & Renshaw analyst Elemer Piros initiates coverage on Mira Pharmaceuticals (NASDAQ:MIRA) with a Buy rating and announces Price Target of $17.
羅德曼與倫肖分析師Elemer Piros開始對Mira Pharmaceuticals (納斯達克:MIRA) 進行覆蓋，給予買入評級並宣佈目標股價爲$17。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間